Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00717691 · ClinicalTrials.gov registry record · NA
Hallux Limitus Treated With Dynamic Splinting: A Randomized, Controlled Trial
A NA study of Hallux Limitus, sponsored by Dynasplint Systems.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT00717691: Completed NA study of Hallux Limitus, sponsored by Dynasplint Systems.
NCT00717691 is a NA study of Hallux Limitus that has completed, run by Dynasplint Systems. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00717691, a NA study of Hallux Limitus, has completed, sponsored by Dynasplint Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to regain range of motion of the great toe with dynamic splinting which will help reduce great toe's pain and swelling.
Conditions Studied
Interventions
- OTHER Standard of Care
- DEVICE Metatarsophalangeal Extension Dynasplint System
Study Locations (2)
Georgia
- Atlanta Foot and Leg Clinic - Jonesboro
- Ankle and Foot Centers, PC - Marietta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-07 |
| Est. Completion | 2008-12 |
| Phase | NA |
What the finished NCT00717691 record still lists
NCT00717691 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Hallux Limitus appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT00717691 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT00717691 about?
NCT00717691 is a clinical study titled "Hallux Limitus Treated With Dynamic Splinting: A Randomized, Controlled Trial". The purpose of this study is to regain range of motion of the great toe with dynamic splinting which will help reduce great toe's pain and swelling.
What is the current status of trial NCT00717691?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2008-07. Estimated completion is 2008-12.
What conditions does trial NCT00717691 study?
This clinical trial studies the following conditions: Hallux Limitus.
What interventions are being tested in trial NCT00717691?
The interventions under investigation include: Standard of Care (OTHER), Metatarsophalangeal Extension Dynasplint System (DEVICE).
Who is sponsoring clinical trial NCT00717691?
This trial is sponsored by Dynasplint Systems, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00717691 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00717691's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia